Previous Close | 0.5645 |
Open | 0.5600 |
Bid | 0.5506 x 100 |
Ask | 0.6064 x 100 |
Day's Range | 0.5600 - 0.5830 |
52 Week Range | 0.5400 - 1.5600 |
Volume | |
Avg. Volume | 137,050 |
Market Cap | 22.145M |
Beta (5Y Monthly) | 0.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.7100 |
Earnings Date | Nov 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.75 |
Bolt Biotherapeutics ( NASDAQ:BOLT ) Third Quarter 2024 Results Key Financial Results Revenue: US$1.14m (down 55% from...
Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of -11.11% and 12.30%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?